Posted by National Health Index
Diabetes News
Thursday, March 22nd, 2012
oig.hhs.gov: March 9, 2012. Criminals who plot to defraud the Government and steal money from the American people have a new target: people with diabetes. Although the precise method may vary, the scheme generally involves someone pretending to be from the Government, a diabetes association, or even Medicare, calling you. The caller offers “free” diabetic […]
Posted by National Health Index
Medicare News
Thursday, March 22nd, 2012
Healthcarefinancenews: | Kelsey Brimmer, Associate Editor, March 19, 2012. WASHINGTON – On Wednesday, the Centers for Medicare & Medicaid Services (CMS) announced a new initiative aimed at avoiding expensive patient readmissions. CMS announced the $128 million Initiative to Reduce Avoidable Hospitalizations among nursing facility residents. CMS will partner with independent organizations to improve care for long-stay nursing facility […]
Posted by National Health Index
Medicare News
Thursday, March 22nd, 2012
By: FRANCES CORREA, Cardiology News Digital Network: 03/16/12. WASHINGTON – By implementing a series of payment reforms now – and adopting MedPAC’s recommendations on replacing the SGR – Congress can fix the Medicare physician pay problem and come closer to paying for it, too. That’s the bottom line of the March 2012 Report to Congress from the Medicare Payment […]
Posted by National Health Index
Medicare News
Thursday, March 22nd, 2012
Avalerehealth: 03.12.12. Florida Medicare Beneficiaries Opting for Managed Care Received Highest Additional Benefits and Reduced Cost Sharing in the Nation Washington, D.C. – An analysis by Avalere Health of data on Medicare private plan payment, released for the first time by the Centers for Medicare & Medicaid Services (CMS), found that nationally Medicare beneficiaries that enrolled […]
Posted by National Health Index
Medicare News
Thursday, March 22nd, 2012
oig.hhs.gov: 03-09-2012. CMS established the Comprehensive Error Rate Testing (CERT) program to produce a national Medicare fee-for-service (FFS) error rate. An error is the difference between the amount that Medicare paid to a health care provider and the amount that it should have paid. Using the results of the CERT program, CMS annually submits to Congress […]
Posted by National Health Index
Clinical Trial News
Thursday, March 22nd, 2012
International Journal for Equity in Health March 19, 2012. Abstract (provisional) Introduction Data supporting external validity of trial results allows clinicians to assess the applicability of a study’s findings to their practice population. Socio-economic status (SES) of trial participants may be critical to external validity given the relationship between social and economic circumstances and health. We […]
Posted by National Health Index
Clinical Trial News
Thursday, March 22nd, 2012
By: MARK S. LESNEY, Cardiology News Digital Network: 03/16/12. Medical device studies have shown persistent underrepresentation of women – a sex gap that could have a profound impact on the health of women who receive such devices. In an attempt to correct this disparity, the Food and Drug Administration’s Center for Devices and Radiological Health (CDRH) issued draft […]
Posted by National Health Index
Clinical Trial News
Thursday, March 22nd, 2012
Sci Transl Med: March 14, 2012. Adverse drug events remain a leading cause of morbidity and mortality around the world. Many adverse events are not detected during clinical trials before a drug receives approval for use in the clinic. Fortunately, as part of postmarketing surveillance, regulatory agencies and other institutions maintain large collections of adverse event […]
Posted by National Health Index
Clinical Trial News
Thursday, March 22nd, 2012
aje.oxfordjournals.org: March 12, 2012. Large prospective cohort studies are critical for identifying etiologic factors for disease, but they require substantial long-term research investment. Such studies can be conducted as multisite consortia of academic medical centers, combinations of smaller ongoing studies, or a single large site such as a dominant regional health-care provider. Still another strategy […]
Posted by National Health Index
Clinical Trial News
Thursday, March 22nd, 2012
Freep: March 11, 2012. The point is not whether it worked. In truth, the research that will determine whether the experimental drug Zoladex protected LeElla Loving-Flake’s fertility during rounds of chemotherapy in 2007 still isn’t complete. Her ovaries might have continued working even if she hadn’t used the drug. At the time, Loving-Flake couldn’t have imagined […]